MRI biomarkers are increasingly used in clinical and preclinical renal research, but results derived by different groups are difficult to compare due to a lack of coherence in the methodology, and different approaches to image acquisition and processing. This is also a barrier to clinical translation, which will require biomarkers that can be compared directly against reference values establishing benchmarks for diagnosis or treatment planning.
Working group 1 will aim to improve the standardisation in the acquisition and analysis of clinical renal MRI data by establishing recommendations that are carried by a broad body of experts, and thus will establish a clear reference baseline for further development and technical and clinical validation. Recommendations will be developed by consensus formation and supported by evidence where available. In order to avoid different standards emerging in different parts of the world, working group 1 will engage experts beyond Europe and/or coordinate efforts with similar initiatives beyond Europe.